Received Feb 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | UNK | N019252 | — |
No additional AE; Improper storage of product in use; This spontaneous report was received from consumer or other non-health professional and referred to a patient of unknown age and gender. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On 06-Feb-2026, the patient was vaccinated with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) suspension for injection (0.50 ml) (batch/lot number: N019252) [Batch/Lot number N019252 is an invalid batch/lot number for Hepatitis B Vaccine (Recombinant)] (expiration date: 06-Sep-2027) dose form was injection (dose text: 2.5/0.5) for prophylaxis. It was reported that the vaccine underwent temperature excursion prior to administration (temperature 37.5 F, time frame 16 hours, no previous temperature excursion) (product storage error). No additional AE (no adverse event) was reported.